Chief Financial Officer
Bill Kullback serves as Chief Financial Officer at Epic Sciences. Mr. Kullback has twenty-seven years of experience as CFO and has held a broad range of financial management and operational roles, primarily in mid-sized to large corporations, including multiple publicly held life science companies where he has a history of completion of significant mergers and acquisitions, and fund-raising success in both private and public markets. Prior to joining Epic, he most recently served as CFO of BioLegend, Inc., a worldwide provider of life science antibodies and reagents, where he led the company’s sale to PerkinElmer (NYSE: PKI) for $5.25 billion, the largest acquisition in PerkinElmer’s history. Prior to BioLegend, Bill was at Lombard Medical, Inc. where he was brought on to assume all aspects of financial management at the company, including its 2017 listing on the Nasdaq. Similar prior CFO appointments at other medical device and technology companies resulted in a host of successful company transactions involving debt, M&A buy-side, M&A sell-side, and public offering transactions. Mr. Kullback earned both his MBA and bachelor’s degrees from the State University of New York at Buffalo, and resides in San Diego, California.